- Home
- DARE vs TENX Comparison
DARE vs TENX Comparison
Compare DARE & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- TENX
- Stock Information
- Founded
- DARE 2015
- TENX 1967
- Country
- DARE United States
- TENX United States
- Employees
- DARE N/A
- TENX N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- DARE Health Care
- TENX Health Care
- Exchange
- DARE Nasdaq
- TENX Nasdaq
- Market Cap
- DARE 28.0M
- TENX 27.3M
- IPO Year
- DARE N/A
- TENX N/A
- Fundamental
- Price
- DARE $2.10
- TENX $6.30
- Analyst Decision
- DARE Strong Buy
- TENX Strong Buy
- Analyst Count
- DARE 2
- TENX 4
- Target Price
- DARE $10.00
- TENX $16.67
- AVG Volume (30 Days)
- DARE 124.8K
- TENX 34.4K
- Earning Date
- DARE 11-13-2025
- TENX 11-12-2025
- Dividend Yield
- DARE N/A
- TENX N/A
- EPS Growth
- DARE N/A
- TENX N/A
- EPS
- DARE N/A
- TENX N/A
- Revenue
- DARE N/A
- TENX N/A
- Revenue This Year
- DARE $6,864.02
- TENX N/A
- Revenue Next Year
- DARE $4,922.46
- TENX N/A
- P/E Ratio
- DARE N/A
- TENX N/A
- Revenue Growth
- DARE N/A
- TENX N/A
- 52 Week Low
- DARE $1.83
- TENX $3.25
- 52 Week High
- DARE $9.19
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- DARE 51.03
- TENX 68.85
- Support Level
- DARE N/A
- TENX $6.02
- Resistance Level
- DARE $2.15
- TENX $6.25
- Average True Range (ATR)
- DARE 0.07
- TENX 0.13
- MACD
- DARE -0.06
- TENX 0.03
- Stochastic Oscillator
- DARE 95.53
- TENX 100.00
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.